Search Results:
1 unique variant retrieved.
Terms with a '*' next to them are explained on the Help Page .
c.3980A>G
p.His1327Arg (Legacy AA No. 1299)
Variant Effect: 
Missense
Codon Change: 
3980A>G
No. of Patients Reported: 
31
Phenotype: 
Asymptomatic
Association: 
thrombosis
Allele Count *: 
15590
Allele Number *: 
277490
Allele Frequency *: 
0.056182
References and Comments:
Castoldi et al 2004
NA
Patient Information:
Show
Patient_ID
|
Age (Yrs)
|
Gender
|
Race
|
FV:C(%)
|
FV:C (IU/dl)
|
FV:Ag(%)
|
FV:Ag (IU/dl)
|
Inheritance
|
Other Variants
|
Severity
|
Comments
|
Reference
|
137 |
NA |
N |
NA |
30 |
NA |
30 |
NA |
Heterozygous |
c.1135_1136delCA (p.His379Phefs*3) |
Asymptomatic |
Mild FV deficiency (>13% FV:C); heterozygous for HR2 haplotype variants
|
Paraboschi et al 2020
|
158 |
NA |
F |
NA |
37 |
NA |
43 |
NA |
Heterozygous |
c.1296+268A>G (NA) |
Asymptomatic |
NA
|
Castoldi et al 2011
|
2 |
NA |
M |
NA |
1 |
NA |
NA |
NA |
Heterozygous |
delexon1-7 (NA)c.1975+5G>A (NA) |
Moderate |
heel pricks and prolonged bleeding, circumcision caused bleeding, bleeding that required a transfusion with blood and fresh-frozen plasma (day 2)
|
Guella et al 2011
|
211 |
NA |
F |
NA |
47 |
NA |
53 |
NA |
Heterozygous |
c.1601G>A (p.Arg534Gln) |
Asymptomatic |
history of venous thrombosis; pseudohomozygous APC resistance
|
Castaman et al 1997
|
212 |
NA |
M |
NA |
45 |
NA |
52 |
NA |
Heterozygous |
c.1601G>A (p.Arg534Gln) |
Asymptomatic |
stroke aged 41; pseudohomozygous APC resistance
|
Castaman et al 1997
|
214 |
NA |
M |
NA |
50 |
NA |
48 |
NA |
Heterozygous |
c.1601G>A (p.Arg534Gln) |
Asymptomatic |
NA
|
Castaman et al 1997
|
271 |
NA |
M |
NA |
1 |
NA |
NA |
NA |
Heterozygous |
delexon1-7 (NA)c.1975+5G>A (NA) |
Moderate |
bleeding post circumcision, bleeding from umbilical venous catheter that required fresh-frozen plasma
|
Guella et al 2011
|
272 |
NA |
M |
NA |
NA |
NA |
NA |
NA |
Heterozygous |
c.1975+5G>A (NA) |
NA |
NA
|
Guella et al 2011
|
475 |
NA |
M |
NA |
77 |
NA |
NA |
NA |
Homozygous |
|
Asymptomatic |
NA
|
Castoldi et al 2004
|
476 |
NA |
M |
NA |
80 |
NA |
NA |
NA |
Homozygous |
|
Asymptomatic |
NA
|
Castoldi et al 2004
|
477 |
NA |
N |
NA |
29 |
NA |
NA |
NA |
Heterozygous |
c.5176C>T (p.Arg1726Trp) |
Asymptomatic |
epistaxis
|
Calzavarini et al 2013
|
478 |
NA |
M |
NA |
45 |
NA |
52 |
NA |
Heterozygous |
c.1601G>A (p.Arg534Gln) |
Asymptomatic |
stroke aged 41; pseudohomozygous APC resistance
|
Castaman et al 1997
|
479 |
NA |
M |
NA |
55 |
NA |
58 |
NA |
Heterozygous |
|
Asymptomatic |
NA
|
Castaman et al 1997
|
480 |
NA |
M |
NA |
50 |
NA |
48 |
NA |
Heterozygous |
c.1601G>A (p.Arg534Gln) |
Asymptomatic |
pseudohomozygous APC resistance
|
Castaman et al 1997
|
481 |
NA |
F |
NA |
47 |
NA |
53 |
NA |
Heterozygous |
c.1601G>A (p.Arg534Gln) |
Asymptomatic |
pseudohomozygous APC resistance
|
Castaman et al 1997
|
482 |
NA |
F |
NA |
36 |
NA |
43 |
NA |
Heterozygous |
c.5189A>G (p.Tyr1730Cys) |
Asymptomatic |
DVT and PE
|
Castoldi et al 2000A
|
483 |
NA |
F |
NA |
37 |
NA |
43 |
NA |
Heterozygous |
c.1296+268A>G (NA) |
Asymptomatic |
NA
|
Castoldi et al 2011
|
484 |
NA |
M |
NA |
1 |
NA |
NA |
NA |
Heterozygous |
delexon1-7 (NA)c.1975+5G>A (NA) |
Moderate |
NA
|
Guella et al 2011
|
485 |
NA |
M |
NA |
NA |
NA |
NA |
NA |
Heterozygous |
c.1975+5G>A (NA) |
NA |
NA
|
Guella et al 2011
|
486 |
NA |
N |
NA |
66 |
NA |
65 |
NA |
Heterozygous |
|
Asymptomatic |
Mild FV deficiency (>13% FV:C)
|
Paraboschi et al 2020
|
487 |
NA |
N |
NA |
30 |
NA |
30 |
NA |
Heterozygous |
c.1135_1136delCA (p.His379Phefs*3) |
Asymptomatic |
Mild FV deficiency (>13% FV:C)
|
Paraboschi et al 2020
|
488 |
NA |
N |
NA |
45 |
NA |
NA |
NA |
Heterozygous |
c.4650C>G (p.Tyr1550*) |
Asymptomatic |
Mild FV deficiency (>13% FV:C)
|
Paraboschi et al 2020
|
489 |
NA |
N |
NA |
36 |
NA |
27 |
NA |
Heterozygous |
|
Asymptomatic |
Mild FV deficiency (>13% FV:C)
|
Paraboschi et al 2020
|
490 |
NA |
N |
NA |
65 |
NA |
60 |
NA |
Heterozygous |
|
Asymptomatic |
Mild FV deficiency (>13% FV:C)
|
Paraboschi et al 2020
|
491 |
NA |
N |
NA |
65 |
NA |
40 |
NA |
Heterozygous |
|
Asymptomatic |
Mild FV deficiency (>13% FV:C)
|
Paraboschi et al 2020
|
492 |
NA |
B |
NA |
NA |
NA |
NA |
NA |
Both |
|
NA |
NA
|
de Visser et al 2000
|
493 |
NA |
N |
NA |
NA |
NA |
NA |
NA |
Not Reported |
|
NA |
NA
|
Le et al 2000
|
494 |
NA |
N |
NA |
NA |
NA |
NA |
NA |
Both |
|
NA |
NA
|
Lunghi et al 1996
|
526 |
NA |
N |
NA |
45 |
NA |
NA |
NA |
Heterozygous |
c.4650C>G (p.Tyr1550*) |
Asymptomatic |
Mild FV deficiency (>13% FV:C)
|
Paraboschi et al 2020
|
572 |
NA |
N |
NA |
29 |
NA |
NA |
NA |
Heterozygous |
c.5176C>T (p.Arg1726Trp) |
Asymptomatic |
epistaxis
|
Calzavarini et al 2013
|
584 |
NA |
F |
NA |
36 |
NA |
43 |
NA |
Heterozygous |
c.5189A>G (p.Tyr1730Cys) |
Asymptomatic |
DVT & PE
|
Castoldi et al 2000A
|
Structural Interpretation:
Please click
HERE
for in-depth variant analysis.
Factor X Variant Database